NRXP: NRX Pharmaceuticals, Inc. Common Stock Company Profile & Statistics

NRX Pharmaceuticals, Inc. Common Stock Profile

About

NRX Pharmaceuticals Inc. is a patient-focused, clinical stage pharmaceutical company. It creates therapies to treat diseases where no medicines currently exist. NRX Pharmaceuticals Inc., formerly known as Big Rock Partners Acquisition Corp., is based in RADNOR, Pa.

Info & Links

CEO

Jonathan Javitt

Headquarters

1201 ORANGE STREET, SUITE 600
WILMINGTON, DE 19801, UNITED STATES

Auditor

Salberg & Company PA

Share holders

Employees

NRX Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

76.49M

Enterprise Value

68.70M

Enterprise Value/EBITDA(ttm)

-4.26

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

29.60%

Operating Margin(ttm)

Profit Margin(ttm)

-599.29%

Return on Equity(ttm)

Return on Invested Capital(ttm)

91.88%

Return on Assets(ttm)

-265.03%

Income Statement

Revenue(ttm)

1.23M

Revenue Per Share(ttm)

0.04

Gross Profit(ttm)

720.00K

EBITDA(ttm)³

-16.12M

Net Income Available to Common(ttm)

-28.62M

Diluted EPS(ttm)

-1.39

Share Statistics

Beta (5Y Monthly)

1.97

52-Week Change

19.40%

S&P 500 52-Week Change

14.48%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

33.07M

Dividend Yield

0.00%

Float⁴

29.83M

% Held by Insiders

6.40%

% Held by Institutions

4.27%

Balance Sheet

Total Cash(mrq)

7.80M

Total Cash Per Share(mrq)

0.24

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.31%

Quick Ratio(mrq)

0.29%

Book Value Per Share(mrq)

-0.50

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.66

Free Cash Flow(ytd)

-14.11M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NRXP

NRX Pharmaceuticals, Inc. Common Stock